Consolidated Stills and Sterilizers Receives OK From FDA to Market its Microprocessor-Controlled Steam Sterilizers
BOSTON -- Consolidated Stills and Sterilizers announced that it has received approval from the Food and Drug Administration (FDA) to market its MARK V microprocessor-controlled steam sterilizers. This approval allows Consolidated to expand its current product offering to the healthcare market. The company will provide an array of sizes and features suitable for operating rooms and central sterile supply.
Consolidated Stills and Sterilizers has produced sterilizers for the global Biotech and Medical-Research markets since 1946.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
